Creo Medical Group PLC (AIM:CREO)

Creo Medical Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	62	40	80	165	46	270
Market Cap Growth	9.60%	-49.48%	-51.66%	261.29%	-83.05%	-10.71%
Enterprise Value	53.46	32.02	75.51	154.89	44.3	236.65
Last Close Price	0.14	0.10	0.20	0.46	0.25	1.49

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	11.65	9.90	-	-	-	-
PS Ratio	10.29	6.72	19.95	41.27	1.68	10.72
PB Ratio	1.24	0.81	1.88	2.76	0.93	3.68
P/TBV Ratio	1.19	0.84	1.72	4.29	2.11	5.32

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	8.91	5.34	18.88	38.72	1.63	9.41

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.04	0.04	0.05	0.09	0.16	0.09
Net Debt / Equity Ratio	-0.17	-0.17	-0.10	-0.17	-0.03	-0.45
Net Debt / EBITDA Ratio	0.49	0.49	0.16	0.43	0.05	1.21
Net Debt / FCF Ratio	0.44	0.44	0.19	0.45	0.05	1.03
Asset Turnover	0.10	0.10	0.06	0.05	0.31	0.26
Inventory Turnover	1.38	1.38	0.39	0.20	1.57	1.77
Quick Ratio	2.47	2.47	0.52	2.74	1.14	2.45
Current Ratio	3.22	3.22	2.75	3.83	1.94	3.10
Return on Equity (ROE)	-37.88%	-37.88%	-54.40%	-43.45%	-43.88%	-36.14%
Return on Assets (ROA)	-28.69%	-28.69%	-38.99%	-31.82%	-30.40%	-24.98%
Return on Invested Capital (ROIC)	-42.69%	-44.61%	-62.96%	-49.54%	-60.58%	-68.87%
Return on Capital Employed (ROCE)	-36.97%	-36.97%	-51.80%	-43.21%	-44.28%	-39.21%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	8.58%	10.10%	-	-	-	-
Buyback Yield / Dilution	-14.38%	-12.26%	-18.20%	-72.61%	-10.28%	-5.54%
Total Shareholder Return	-14.38%	-12.26%	-18.20%	-72.61%	-10.28%	-5.54%

Data Source: Fiscal.ai Last updated: May 22, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 27, 2026

Data Sources Report a data error